
Kronox Lab Sciences IPO
- Issue price
- ₹136
- Listing price
- ₹164.95
- +21.29%
- Current price
- ₹192.71
- +41.70%
- Subscribed
- 117.25x
- Issue size
- ₹130.15 Cr
- Listed on
- 10 Jun 2024
IPO timeline
- Opens3 JunMon
- Closes5 JunWed
- Allotment6 JunThu
- Refunds7 JunFri
- Demat credit7 JunFri
- Listing10 JunMon
Issue details
- Price band
- ₹129 – ₹136 per share
- Issue size
- ₹130.15 Cr
- Fresh issue
- None
- Offer for sale
- ₹130.15 Cr
- Issue type
- OFS only
- Face value
- ₹10 per share
- Lot size
- 110 shares
- Minimum investment
- ₹14,960
- Listing on
- BSE, NSE
- Exchange code
- KRONOX · 544187
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1,430 | ₹1,94,480 |
| S-HNI (Min) | 14 | 1,540 | ₹2,09,440 |
| B-HNI (Min) | 67 | 7,370 | ₹10,02,320 |
Reservation
- QIB
- 47,85,000 shares (50.00% of the Offer)
- NII
- 14,35,500 shares (15.00% of the Offer)
- Retail
- 33,49,500 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 6 Jun 2024
- Refunds initiated
- 7 Jun 2024
- Shares credited to demat
- 7 Jun 2024
- Listing
- 10 Jun 2024
Grey market premium (GMP)
- Current GMP
- ₹36
- +26.00%
- Estimated listing price
- ₹172
- Issue price ₹136
- Highest
- ₹75
- 3 Jun
- Lowest
- ₹36
- 5 Jun
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 5 Jun 2024 | ₹36 | +26.00% | ₹172 |
| 4 Jun 2024 | ₹40 | +29.00% | ₹176 |
| 3 Jun 2024 | ₹75 | +55.00% | ₹211 |
| 2 Jun 2024 | ₹70 | +51.00% | ₹206 |
| 31 May 2024 | ₹70 | +51.00% | ₹206 |
| 30 May 2024 | ₹70 | +51.00% | ₹206 |
| 29 May 2024 | ₹70 | +51.00% | ₹206 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB89.03x
- NII (HNI)301.92x
- Retail54.24x
Financials
- P/E (pre-issue)
- 24.47
- P/E (post-issue)
- 24.47
- EPS (₹)
- 5.56
- RoE
- 25.66%
- RoCE
- 33.15%
- RoNW
- 25.66%
- PAT Margin
- 22.60%
- NAV (₹)
- 16.25
Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price.
| Period ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Total Income | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| NET Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | 0.64 | 0.01 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Kronox Lab Sciences This IPO | ₹130.15 Cr | 24.47 | 25.66% | 22.60% | 117.25x | +21.29% |
| Amanta Healthcare Mainboard · listed 9 Sep 2025 | ₹126 Cr | 46.59 | 10.89% | 3.86% | 82.6x | +7.14% |
| Hexagon Nutrition Mainboard · listed 12 Jun 2026 | ₹138.87 Cr | 15.35 | 12.12% | 9.81% | 53.68x | +7.22% |
| Anlon Healthcare Mainboard · listed 3 Sep 2025 | ₹121.03 Cr | 23.57 | 25.51% | 17.06% | 7.12x | +1.10% |
| Gaudium IVF Mainboard · listed 27 Feb 2026 | ₹165 Cr | 22.99 | 41.71% | 26.96% | 7.27x | +5.06% |
| Gujarat Kidney & Super Speciality Mainboard · listed 30 Dec 2025 | ₹250.8 Cr | 61.62 | 36.61% | 23.61% | 5.21x | +5.26% |
| Sai Parenteral's Mainboard · listed 2 Apr 2026 | ₹409 Cr | 72.19 | 5.09% | 8.93% | 1.08x | +2.04% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
About Kronox Lab Sciences
Kronox Lab Sciences Limited was incorporated in 2008. It makes high purity speciality fine chemicals for many end-user industries. Its products are used in making APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries and animal health. It offers more than 185 products across the phosphate, sulphate, acetate, chloride, citrate and other families, and supplies customers in India and more than 20 countries. The IPO was Rs 130.15 crore and was entirely an offer for sale by the three promoters, so the company received none of the money.
Strengths
- Profit after tax rose from Rs 9.73 crore in FY2021 to Rs 16.62 crore in FY2023.
- The source puts the PAT margin at 22.60% and return on net worth at 25.66%.
- Borrowing was negligible, at Rs 0.64 crore on 31 March 2022.
- Profit after tax was Rs 15.47 crore in the nine months to 31 December 2023.
- It sells more than 185 products to customers in over 20 countries.
Risks
- The whole Rs 130.15 crore issue was offer for sale by the promoters, so no money went to the company.
- The pre-issue P/E was 30.37 at the upper band of Rs 136, based on EPS of Rs 4.48.
- The company is small, with total income of Rs 97.50 crore in FY2023.
- Its customers are in regulated sectors such as pharma, so quality failures would be costly. Net worth was Rs 60.28 crore.
- Promoters held 100% before the issue and 74.21% after it.
Promoters and shareholding
Jogindersingh Jaswal, Ketan Ramani and Pritesh Ramani
- Promoter holding, pre-issue
- 100%
- Promoter holding, post-issue
- 74.21%
Anchor investors
| Investor | Shares allotted | Amount | % of anchor book |
|---|---|---|---|
| NEGEN UNDISCOVERED VALUE FUND | 5,57,260 | ₹7.58 Cr | 19.41% |
| CHANAKYA OPPORTUNITIES FUND I | 5,50,330 | ₹7.48 Cr | 19.17% |
| MINERVA EMERGING OPPORTUNITIES FUND LIMITED | 5,50,330 | ₹7.48 Cr | 19.17% |
| CAPRI GLOBAL CAPITAL LIMITED | 4,04,360 | ₹5.5 Cr | 14.08% |
| MONEYWISE FINANCIAL SERVICES PRIVATE LIMITED | 4,04,360 | ₹5.5 Cr | 14.08% |
| VPK GLOBAL VENTURES FUND-VPK GLOBAL VENTURES FUND-SCHEME I | 4,04,360 | ₹5.5 Cr | 14.08% |
Registrar, lead managers and documents
Lead manager
Documents
Kronox Lab Sciences IPO: common questions
1.When does the Kronox Lab Sciences IPO open and close?
The Kronox Lab Sciences IPO opens on 3 Jun 2024 and closes on 5 Jun 2024.
2.What is the price band of the Kronox Lab Sciences IPO?
The price band is ₹129 – ₹136 per share, with a lot size of 110 shares and a minimum investment of ₹14,960.
3.What is the size of the Kronox Lab Sciences IPO?
The issue size is ₹130.15 Cr (OFS only).
4.What is the GMP of the Kronox Lab Sciences IPO?
The last reported grey market premium is ₹36 per share as of 05 Jun 2024, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Kronox Lab Sciences IPO allotment?
The basis of allotment is expected on 6 Jun 2024. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Kronox Lab Sciences IPO list?
The shares listed on 10 Jun 2024 on BSE, NSE.
7.Who is the lead manager of the Kronox Lab Sciences IPO?
The book running lead manager is Pantomath Capital Advisors Pvt Ltd, and the registrar is KFin Technologies Limited.
8.How can my company launch an IPO like Kronox Lab Sciences?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393